Murni Sadar Tbk PT
The company's capital structure is characterized by a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. Its liquidity position is assessed as medium, with a current ratio of 0.43, suggesting potential challenges in meeting short-term obligations. The company's valuation metrics, including a price-to-earnings ratio of 48.84 and a price-to-book ratio of 1.44, suggest that the market is valuing the company at a premium relative to its book value and earnings. In terms of profitability, the company's return on equity is 2.95%, and its return on assets is 1.65%, which are below the industry norms for healthcare facilities and services. The company's operating income margin is 8.35%, and its net income margin is 3.21%, which are also below the industry median. The company's geographic exposure is concentrated in Indonesia, with operations in Medan, Jakarta, Tangerang, and Bali. The revenue concentration in these regions is not disclosed, but the company's operations are subject to the economic and regulatory environment of Indonesia. The company's segments are not disclosed in detail, but the services offered include outpatient installation, laboratory, radiology, and endoscopy. The company's growth trajectory is expected to be modest, with the current fiscal year's outlook indicating a slight increase in revenue. The next fiscal year's outlook is also positive, with a projected increase in revenue. The company's capital expenditure is negative, indicating a reduction in investment in new facilities or equipment. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flags include a negative net cash position after subtracting total debt, which could affect the company's ability to fund operations and investments. The company's dilution potential is low, and no significant adjustments have been applied to the valuation metrics. Recent events related to the company include the latest financial snapshot, which provides an overview of the company's financial position as of the latest available data. The company's financial performance is subject to the economic conditions in Indonesia and the healthcare sector.
Business. PT Murni Sadar Tbk operates private hospitals in Indonesia, offering a range of health services including outpatient care, laboratory, radiology, and endoscopy services, with a total bed capacity of 1,061 units.
Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.
- The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.52.
- The company's profitability metrics, including return on equity and return on assets, are below industry norms.
- The company's liquidity position is assessed as medium, with a current ratio of 0.43.
- The company's growth trajectory is expected to be modest, with a projected increase in revenue for the next fiscal year.
- The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk.
- # RATIONALES
- margin_outlook_rationale: The company's operating and net income margins are below industry norms, indicating potential challenges in maintaining profitability.
- rd_outlook_rationale: The company's research and development outlook is not disclosed, but the healthcare sector typically requires ongoing investment in new services and technologies.
- Net cash is negative after subtracting total debt.